This website is intended for healthcare professionals only.

Newsletter          
Hospital Healthcare Europe
HOPE LOGO
Hospital Healthcare Europe

Are you up to date with the latest economic data behind TAVI in low-risk patients?

A 2022 paper has confirmed the cost effectiveness of TAVI, with cost-savings being most pronounced in patients with low surgical risk. Stay up to date with our new key paper summary!

VIEW AND DOWNLOAD

EuroPCR 2022 highlights

Check out our report on the key symposia from EuroPCR 2022; from the importance of valve choice in younger, low-risk patients, to how to increase capacity for TAVI in your hospital.

READ NOW

Access to TAVI in Europe: how can we overcome long waiting lists?

Our new infographic highlights the impact of long TAVI waiting lists on morbidity and mortality rates in Europe, as well as ways to tackle to backlog of aortic stenosis cases.

VIEW NOW

Long waiting lists increase risk of mortality following the TAVI procedure

Check out our new key paper evaluation on a 2022 trial emphasising the importance of reducing TAVI waiting lists and minimising preventable deaths.

View and download

STAY UP TO DATE

Subscribe

OR GET IN TOUCH TO LEARN MORE

A trip down memory lane: How far has TAVI come?


TAVI Resources

View all resources

EuroPCR 2022 highlights

Check out our report on the key symposia from EuroPCR 2022; from the importance of valve choice in younger, low-risk patients, to how to increase capacity for TAVI in your hospital.

Access to TAVI in Europe: how can we overcome long waiting lists?

Our new infographic highlights the impact of long TAVI waiting lists on morbidity and mortality rates in Europe. It also walks through ways to tackle to backlog of aortic stenosis cases, while minimising the resulting number of deaths.

Availability of Cardiovascular Care

The European Society of Cardiology (ESC) Atlas undertakes an annual survey to obtain data on cardiovascular procedure rates across ESC member countries, and the variation in human and capital resources that underpin this variation.

Key paper evaluations

View more papers

Carcinogens, Mutagens and Reprotoxic substances Directive (CMRD)

Authors: Baron SJ, Ryan MP, Moore KA, et al.

Citation: Circ Cardiovasc Intervent. 2022;15:e011295. DOI:10.1161/CIRCINTERVENTIONS.121.011295.

Impact of wait times on late postprocedural mortality after successful transcatheter aortic valve replacement 

Authors: Roule V, Rebouh I, Lemaitre A, Sabatier R, et al.

Citation: Scientific Reports. 2022;12(1):5967. DOI:10.1038/s41598-022-09995-z.

Drivers and outcomes of variation in surgical versus transcatheter aortic valve replacement in Ontario, Canada: a population-based study

Authors:  Miranda RN, Qiu F, Manoragavan R, et al.

Citation: Open Heart 2022;9:e001881. DOI:10.1136/openhrt-2021-001881.